DERMATOLOGICAL THERAPEUTIC MARKET ANALYSIS

Dermatological Therapeutic Market, By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Acne Vulgaris, Vitiligo, Hidradenitis, and Other Applications), By Drug Class (Anti-infectives, Corticosteroids, Calcineurin Inhibitors, Retinoids, and Other Drug Classes), By Geography (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023
Code : CMI5490
Pages :164
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Leo Pharma, Pfizer Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline PLC, Galderma, Amgen Inc., Almirall, S.A., XBiotech USA Inc., AbbVie Inc, and Bausch Health Companies Inc., among others.

Global Dermatological Therapeutic Market: Key Companies Insights

The global dermatological therapeutic market is highly competitive. This is attributed to the rise in demand for safe and effective therapeutics, as a result, market players are focusing on launching novel products in the market.

Some of the key players in the global dermatological therapeutic market are Leo Pharma, Pfizer Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline PLC, Galderma, Amgen Inc., Almirall, S.A., XBiotech USA Inc., AbbVie Inc, and Bausch Health Companies Inc., among others.